CHARACTERIZATION OF BIOCHEMICAL RESPONSES OF ANGIOTENSIN-II (AT2) BINDING-SITES IN THE RAT PHEOCHROMOCYTOMA PC12W CELLS

被引:52
作者
LEUNG, KH [1 ]
ROSCOE, WA [1 ]
SMITH, RD [1 ]
TIMMERMANS, PBMWM [1 ]
CHIU, AT [1 ]
机构
[1] DUPONT MERCK PHARMACEUT CO, POB 80400, WILMINGTON, DE 19880 USA
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1992年 / 227卷 / 01期
关键词
PC12W; ANGIOTENSIN-II RECEPTOR SUBTYPES; SIGNAL TRANSDUCTION PATHWAYS;
D O I
10.1016/0922-4106(92)90143-J
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Rat pheochromocytoma PC12W cell membranes have previously been shown to exclusively contain the AT2 receptor subtype. The present study extended these binding data and explored the functional expression of these binding sites. Our binding competition studies show a potency series of Ang II = Ang III > saralasin > Ang I = PD123177 much greater than Ang II(1-7) >>> losartan. PD123177 (1-mu-M) completely eliminated [I-125]Ang II binding to PC12W cells. Competitive displacement of [I-125]Ang II with Ang II shows a dissociation equilibrium constant (K(d)) of 1.79 nM and a binding site maximum (B(max)) of 3.97 fmol/mg protein. Investigating several Ang II signal transduction pathways on these cells, we found that Ang II (10(-8) to 10(-6) M) docs not affect basal cAMP, cGMP, arachidonic acid release, prostacyclin release, intracellular Ca2+ mobilization or thymidine incorporation in the PC12W cells. Nerve growth factor, cAMP, 5-fluorouridine deoxyriboside modulation of the number of AT2 receptor sites in PC12W cells failed to unmask any Ang II effects on basal cAMP, cGMP and intracellular Ca2+ mobilization. In conclusion, the present study confirms the exclusive presence of AT2 binding sites in the PC12W cells. However, these binding sites are not functionally coupled to common signal transduction pathways.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 36 条
[1]  
BALLA T, 1991, MOL PHARMACOL, V40, P401
[2]   ANGIOTENSIN-II AT2 RECEPTORS DO NOT INTERACT WITH GUANINE-NUCLEOTIDE BINDING-PROTEINS [J].
BOTTARI, SP ;
TAYLOR, V ;
KING, IN ;
BOGDAL, Y ;
WHITEBREAD, S ;
DEGASPARO, M .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1991, 207 (02) :157-163
[3]   NOMENCLATURE FOR ANGIOTENSIN RECEPTORS - A REPORT OF THE NOMENCLATURE-COMMITTEE OF THE COUNCIL-FOR-HIGH-BLOOD-PRESSURE-RESEARCH [J].
BUMPUS, FM ;
CATT, KJ ;
CHIU, AT ;
DEGASPARO, M ;
GOODFRIEND, T ;
HUSAIN, A ;
PEACH, MJ ;
TAYLOR, DG ;
TIMMERMANS, PBMWM .
HYPERTENSION, 1991, 17 (05) :720-721
[4]   CELL-CYCLE DEPENDENT COUPLING OF THE CALCITONIN RECEPTOR TO DIFFERENT G-PROTEINS [J].
CHAKRABORTY, M ;
CHATTERJEE, D ;
KELLOKUMPU, S ;
RASMUSSEN, H ;
BARON, R .
SCIENCE, 1991, 251 (4997) :1078-1082
[5]  
CHANG RSL, 1990, MOL PHARMACOL, V37, P347
[6]   COMPARISON OF THE EFFECTS OF ANGIOTENSIN-II AND VASOPRESSIN ON CYTOSOLIC FREE CALCIUM-CONCENTRATION, PROTEIN KINASE-C ACTIVITY, AND PROSTACYCLIN PRODUCTION IN CULTURED RAT AORTIC AND MESENTERIC SMOOTH-MUSCLE CELLS [J].
CHARDONNENS, D ;
LANG, U ;
CAPPONI, AM ;
VALLOTTON, MB .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 :S39-S44
[7]  
Chiu A T, 1991, Receptor, V1, P133
[8]  
CHIU AT, 1990, J PHARMACOL EXP THER, V252, P711
[9]   IDENTIFICATION OF ANGIOTENSIN-II RECEPTOR SUBTYPES [J].
CHIU, AT ;
HERBLIN, WF ;
MCCALL, DE ;
ARDECKY, RJ ;
CARINI, DJ ;
DUNCIA, JV ;
PEASE, LJ ;
WONG, PC ;
WEXLER, RR ;
JOHNSON, AL ;
TIMMERMANS, PBMWM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (01) :196-203
[10]  
DUDLEY DT, 1991, MOL PHARMACOL, V40, P360